Oralgen oral insulin: GNBT will start Phase II testing

Generex Biotechnology Corp. (GNBT), Toronto, Ontario Product: Oralgen oral insulin Indication: Treat Types I and II diabetes Status: GNBT will start Phase II testing in the U.S. by the end of 1998 w...